Kevin Lynch

Kevin Lynch, Ph.D. has more than 25 years of pharmaceutical industry experience, with the majority being in the business development and strategy space. Kevin is currently Vice President of Business Development at Vir Biotechnology. Previously, he was Chief Business Officer at Recursion Pharmaceuticals. Prior to that, Kevin was VP and Head of the Global Search and Evaluation group at Abbvie. He also worked in additional business development roles at Abbott/Abbvie and led many successful transactions to grow the companies’ therapeutics portfolio. Prior to this, Kevin was one of the founding members of Abbott’s R&D portfolio analysis and strategic decision support group. He has also served on the Board of Directors for two-state biotechnology associations.

Before joining Abbott as a research molecular biologist, Kevin worked in the Gene Medicine Department at Rhone-Poulenc Rorer Pharmaceuticals. Kevin received his Ph.D. in Microbiology and held an NIH post-doctoral fellowship at the Pennsylvania State University, as well as an MBA from Northwestern University Kellogg School of Management.